Clinical Trial Update: Transdermal Delivery of Glucosamine to the Synovial Fluid of Male and Female With Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on transdermal delivery of glucosamine to the knee synovial fluid in adults with knee osteoarthritis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• Glucosamine (glucosamine)

Snippet

Sponsor: Lynk Biotechnologies Pte Ltd | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED